Tikun Olam-Cannbit Pharmaceuticals Ltd

Tel Aviv Stock Exchange TKUN.TA

Tikun Olam-Cannbit Pharmaceuticals Ltd Debt to Equity Ratio for the year ending December 31, 2023: 0.49

Tikun Olam-Cannbit Pharmaceuticals Ltd Debt to Equity Ratio is 0.49 for the year ending December 31, 2023, a 204.91% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.
  • Tikun Olam-Cannbit Pharmaceuticals Ltd Debt to Equity Ratio for the year ending December 31, 2022 was 0.16, a 21.05% change year over year.
  • Tikun Olam-Cannbit Pharmaceuticals Ltd Debt to Equity Ratio for the year ending December 31, 2021 was 0.13, a 12.07% change year over year.
  • Tikun Olam-Cannbit Pharmaceuticals Ltd Debt to Equity Ratio for the year ending December 31, 2020 was 0.12, a -28.26% change year over year.
  • Tikun Olam-Cannbit Pharmaceuticals Ltd Debt to Equity Ratio for the year ending December 31, 2019 was 0.17.
Key data
Date Debt to Equity Ratio Debt to Income Ratio Debt to Tangible Net Worth Ratio Dividend Coverage Ratio
Market news
SV Wall Street
Tel Aviv Stock Exchange: TKUN.TA

Tikun Olam-Cannbit Pharmaceuticals Ltd

CEO Mr. Ronen Elad
IPO Date Aug. 12, 2002
Location Israel
Headquarters Hitad 2
Employees 50
Sector Health Care
Industries
Pharmaceuticals
Description

Tikun Olam-Cannbit Pharmaceuticals Ltd engages in the research, development, cultivation, manufacture, and distribution of medical cannabis and related products. It also provides training and patient care services. The company is based in Nof Hagalil, Israel.

StockViz Staff

January 30, 2025

Any question? Send us an email